Proceeding in a receding economy.
The biotech sector must not only maintain an emphasis on ground-breaking products and focus on retaining key staff but also mobilize to ensure that US health policy continues to reward its innovations.
Scangos
George A
GA
Exelixis, Inc., South San Francisco, California, USA. scangos@exelixis.com
D001709:Biotechnology / Q000191:economics* / Q000458:organization & administration / Q000639:trends; D018166:Health Care Reform; D017149:Private Sector; D014481:United States